Literature DB >> 24969560

Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs.

Wei-Xian Chen1, Yan-Qin Cai, Meng-Meng Lv, Lin Chen, Shan-Liang Zhong, Teng-Fei Ma, Jian-Hua Zhao, Jin-Hai Tang.   

Abstract

Breast cancer (BCa) remains chemo-unresponsive by inevitable progression of resistance to first-line treatment with docetaxel (doc). Emerging studies indicate that exosomes act as mediators of intercellular communication between heterogeneous populations of tumor cells, engendering a transmitted drug resistance for cancer development. Such modulatory effects have been related to the constant shuttle of biologically active molecules including microRNAs (miRNAs). Here, we aimed to investigate the relevance of exosome-mediated miRNA delivery in resistance transmission of BCa subpopulations. Using microarray and polymerase chain reaction, we found that exosomes from doc-resistant BCa cells (D/exo) loaded cellular miRNAs. Following D/exo transfer to the fluorescent sensitive cells (GFP-S), some miRNAs were significantly increased in recipient GFP-S. Target gene prediction and pathway analysis revealed the involvement of the top 20 most abundant miRNAs of D/exo in pathways implicated in therapy failure. Coculture assays showed that miRNA-containing D/exo increased the overall resistance of GFP-S to doc exposure. Moreover, D/exo was able to alter gene expression in GFP-S. Our results open up an intriguing possibility that drug-resistant BCa cells may spread chemoresistance to sensitive ones by releasing exosomes and that the effects could be partly attributed to the intercellular transfer of specific miRNAs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969560     DOI: 10.1007/s13277-014-2242-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Authors:  Shanliang Zhong; Wenjing Li; Zhiyuan Chen; Jinjin Xu; Jianhua Zhao
Journal:  Gene       Date:  2013-08-29       Impact factor: 3.688

2.  Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth.

Authors:  Takayuki Kogure; Wen-Lang Lin; Irene K Yan; Chiara Braconi; Tushar Patel
Journal:  Hepatology       Date:  2011-07-29       Impact factor: 17.425

3.  Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.

Authors:  Paulina Kucharzewska; Helena C Christianson; Johanna E Welch; Katrin J Svensson; Erik Fredlund; Markus Ringnér; Matthias Mörgelin; Erika Bourseau-Guilmain; Johan Bengzon; Mattias Belting
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

Review 4.  Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA.

Authors:  Yuriy Gusev
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

5.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

6.  Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.

Authors:  Shizhen Emily Wang; Bin Xiang; Marta Guix; Maria Graciela Olivares; Joel Parker; Christine H Chung; Atanasio Pandiella; Carlos L Arteaga
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

7.  In vitro and in vivo validation of human and goat chondrocyte labeling by green fluorescent protein lentivirus transduction.

Authors:  Sylvie Miot; Roberto Gianni-Barrera; Karoliina Pelttari; Chitrangada Acharya; Pierre Mainil-Varlet; Henriette Juelke; Claude Jaquiery; Christian Candrian; Andrea Barbero; Ivan Martin
Journal:  Tissue Eng Part C Methods       Date:  2010-02       Impact factor: 3.056

8.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

9.  MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.

Authors:  Xiu-juan Li; Ming-hua Ji; Shan-liang Zhong; Quan-bing Zha; Jin-jin Xu; Jian-hua Zhao; Jin-hai Tang
Journal:  Arch Med Res       Date:  2012-10-16       Impact factor: 2.235

10.  The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.

Authors:  Yan Ni Loh; Ellen L Hedditch; Laura A Baker; Eve Jary; Robyn L Ward; Caroline E Ford
Journal:  BMC Cancer       Date:  2013-04-02       Impact factor: 4.430

View more
  65 in total

Review 1.  Extracellular vesicles in breast cancer drug resistance and their clinical application.

Authors:  Shentong Yu; Yifang Wei; Yuqiao Xu; Yuan Zhang; Jipeng Li; Jian Zhang
Journal:  Tumour Biol       Date:  2016-01-21

Review 2.  Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.

Authors:  Valentina R Minciacchi; Michael R Freeman; Dolores Di Vizio
Journal:  Semin Cell Dev Biol       Date:  2015-02-23       Impact factor: 7.727

3.  Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer.

Authors:  Roman Samsonov; Vladimir Burdakov; Tatiana Shtam; Zamira Radzhabovа; Dmitry Vasilyev; Evgenia Tsyrlina; Sergey Titov; Michail Ivanov; Lev Berstein; Michael Filatov; Nikolay Kolesnikov; Hava Gil-Henn; Anastasia Malek
Journal:  Tumour Biol       Date:  2016-05-11

Review 4.  Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment.

Authors:  C-Y Wu; S-L Du; J Zhang; A-L Liang; Y-J Liu
Journal:  Cancer Gene Ther       Date:  2016-12-16       Impact factor: 5.987

Review 5.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

6.  Exosome-mediated drug resistance in cancer: the near future is here.

Authors:  Marco Giallombardo; Simona Taverna; Riccardo Alessandro; David Hong; Christian Rolfo
Journal:  Ther Adv Med Oncol       Date:  2016-05-12       Impact factor: 8.168

Review 7.  Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro; Luis Otávio Sarian; Manoela Marques Ortega; Sophie Françoise Derchain
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

8.  Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.

Authors:  Dan-Dan Yu; Ying Wu; Xiao-Hui Zhang; Meng-Meng Lv; Wei-Xian Chen; Xiu Chen; Su-Jin Yang; Hongyu Shen; Shan-Liang Zhong; Jin-Hai Tang; Jian-Hua Zhao
Journal:  Tumour Biol       Date:  2015-10-02

9.  Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles.

Authors:  Xin Ma; Zhaohui Li; Ting Li; Linwensi Zhu; Zhenshengnan Li; Nan Tian
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

10.  From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis.

Authors:  Ilaria Giusti; Simona Delle Monache; Marianna Di Francesco; Patrizia Sanità; Sandra D'Ascenzo; Giovanni Luca Gravina; Claudio Festuccia; Vincenza Dolo
Journal:  Tumour Biol       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.